HIGHLIGHTS
- who: Report and colleagues from the Internal Medicine, Saint Agnes Medical Center, Fresno, USA have published the article: Review began 09/16/2022 Review ended 09/27/2022 Published 09/30/2022 u00a9 Copyright, in the Journal: (JOURNAL) of September/30,/2022
- what: Report, our patient continued to endorse symptoms for five months.
SUMMARY
Hydralazine was implemented into daily use to treat hypertension in 1951. Hydralazine leading to lupus-like symptoms has an incidence rate of approximately 7% and most commonly presents with fever, myalgias, fatigue, rash, serositis, arthritis, pleural effusion . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.